Lincoln Capital Corp Abbott Laboratories Transaction History

Lincoln Capital Corp

$232 Million
Q4 2024

A detailed history of Lincoln Capital Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Lincoln Capital Corp holds 7,154 shares of ABT stock, worth $881,515. This represents 0.35% of its overall portfolio holdings.

Number of Shares

7,154

Previous 7,154 -0.0%

Holding current value

$881,515

Previous $815,000 0.74%

% of portfolio

0.35%

Previous 0.34%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$100.73 - $112.44 $65,172 - $72,748	-647 Reduced 8.29%	7,154 $743,000
Q1 2024 Apr 15, 2024	SELL	$109.52 - $120.96 $186,184 - $205,632	-1,700 Reduced 17.89%	7,801 $886,000
Q4 2023 Jan 18, 2024	SELL	$90.19 - $110.4 $14,520 - $17,774	-161 Reduced 1.67%	9,501 $1.05 Million
Q1 2023 Apr 20, 2023	SELL	$96.86 - $114.01 $24,215 - $28,502	-250 Reduced 2.52%	9,662 $978,000
Q3 2022 Oct 24, 2022	SELL	$96.76 - $112.03 $63,764 - $73,827	-659 Reduced 6.23%	9,912 $959,000
Q2 2022 Jul 22, 2022	SELL	$102.07 - $123.37 $5,103 - $6,168	-50 Reduced 0.47%	10,571 $1.15 Million
Q1 2022 Apr 19, 2022	SELL	$114.02 - $139.04 $9,121 - $11,123	-80 Reduced 0.75%	10,621 $1.26 Million
Q4 2021 Jan 24, 2022	BUY	$115.53 - $141.46 $10,397 - $12,731	90 Added 0.85%	10,701 $1.51 Million
Q3 2021 Oct 18, 2021	BUY	$116.66 - $129.06 $10,732 - $11,873	92 Added 0.87%	10,611 $1.25 Million
Q2 2021 Jul 22, 2021	BUY	$105.79 - $124.53 $64,214 - $75,589	607 Added 6.12%	10,519 $1.22 Million
Q2 2020 Jul 22, 2020	SELL	$76.57 - $98.0 $38,285 - $49,000	-500 Reduced 4.8%	9,912 $906,000
Q1 2020 Apr 16, 2020	SELL	$62.82 - $91.86 $18,343 - $26,823	-292 Reduced 2.73%	10,412 $822,000
Q4 2019 Jan 17, 2020	SELL	$78.51 - $87.4 $94,212 - $104,880	-1,200 Reduced 10.08%	10,704 $930,000
Q2 2019 Jul 12, 2019	SELL	$72.88 - $85.0 $21,864 - $25,500	-300 Reduced 2.46%	11,904 $1 Million
Q2 2018 Jul 26, 2018	SELL	$57.57 - $63.54 $93,148 - $102,807	-1,618 Reduced 11.71%	12,204 $744,000
Q1 2018 Apr 12, 2018	SELL	$56.27 - $63.62 $3.77 Million - $4.27 Million	-67,071 Reduced 82.91%	13,822 $282,000
Q4 2017 Feb 06, 2018	BUY	$53.68 - $57.47 $39,991 - $42,815	745 Added 0.93%	80,893 $4.62 Million
Q3 2017 Oct 18, 2017	BUY	$48.06 - $53.64 $3.85 Million - $4.3 Million	80,148	80,148 $4.28 Million

Others Institutions Holding ABT

# of Institutions

3,204

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $216B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln Capital Corp with notifications on news.

Account

Lincoln Capital Corp Abbott Laboratories Transaction History